Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
CHRS•Coherus Oncology announces special dividend and legacy biosimilar sale process
- Coherus Oncology Inc. announced a special dividend of biosimilar contingent value rights.
- Coherus Oncology said it will begin a sale process for legacy biosimilar assets.
